Artemisinin based combination therapy in travel medicine

Travel Medicine and Infectious Disease

Volumn 11, Issue 1, 2013, Pages 23-28

  Jelinek, Tomas ^a  

^a Berlin Center for Travel and Tropical Medicine   (Germany)

Author keywords

Artemether lumefantrine; Artemisinin combination therapy; Dihydroartemisinin piperaquine; Stand by emergency treatment; Travellers malaria

Indexed keywords

ARTEMETHER PLUS BENFLUMETOL; ARTEMISININ; ARTESUNATE; ATOVAQUONE; BENFLUMETOL; CHLOROQUINE; CLINDAMYCIN; DIHYDROARTEMISININ; DIHYDROARTEMISININ PLUS PIPERAQUINE; DOXYCYCLINE; MEFLOQUINE; PIPERAQUINE; PROGUANIL; QUININE;

ANTIMALARIAL ACTIVITY; CHEMOPROPHYLAXIS; CLINICAL FEATURE; CRITICALLY ILL PATIENT; DRUG ABSORPTION; DRUG CLEARANCE; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG HALF LIFE; EMERGENCY CARE; EMPORIATRICS; FALSE NEGATIVE RESULT; GOLD STANDARD; HEALTH CARE POLICY; HUMAN; MALARIA; MALARIA FALCIPARUM; MICROBIAL BIOMASS; MONOTHERAPY; OUTPATIENT CARE; PARASITE CLEARANCE; PATIENT COMPLIANCE; PLASMODIUM FALCIPARUM; PLASMODIUM KNOWLESI; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; SYMPTOM; TRAVEL; TREATMENT DURATION; UNSPECIFIED SIDE EFFECT;

ANTIMALARIALS; ARTEMISININS; DRUG THERAPY, COMBINATION; EMERGENCY TREATMENT; HUMANS; MALARIA; MALARIA, FALCIPARUM; PLASMODIUM FALCIPARUM; PRACTICE GUIDELINES AS TOPIC; TRAVEL MEDICINE; WORLD HEALTH ORGANIZATION;

EID: 84875728707     PISSN: 14778939     EISSN: 18730442     Source Type: Journal    
DOI: 10.1016/j.tmaid.2013.01.005     Document Type: Review

References (65)

1. R.E. Cibulskis, M. Aregawi, R. Williams, M. Otten, and C. Dye Worldwide incidence of malaria in 2009: estimates, time trends, and a critique of methods PLoS Med 8 2011 e1001142 10.1371/journal.pmed.1001142
2. C.J. Murray, L.C. Rosenfeld, S.S. Lim, K.G. Andrews, K.J. Foreman, and D. Haring Global malaria mortality between 1980 and 2010: a systematic analysis Lancet 379 2012 413 431 10.1016/S0140-6736(12)60034-8
3. World Health Organization World malaria report 2011 2011 WHO Geneva http://www.who.int/malaria/world-malaria-report-2011/en/ [accessed 13.12.12]
4. P. Schlagenhauf, and E. Petersen Standby emergency treatment of malaria in travelers Expert Rev Anti Infect Ther 10 2012 537 546
5. K. Leder, S. Tong, L. Weld, K.C. Kain, A. Wilder-Smith, and F. von Sonnenburg Illness in travelers visiting friends and relatives: a review of the GeoSentinel Surveillance Network Clin Infect Dis 43 2006 1185 1193
6. T. Jelinek, C. Schulte, R. Behrens, M.P. Grobusch, J.P. Coulaud, and Z. Bisoffi Clinical and epidemiological characteristics of falciparum malaria among travellers and immigrants with imported falciparum malaria in Europe: sentinel surveillance data from TropNetEurop Clin Infect Dis 34 2002 572 576
7. P.A. Phillips-Howard, D.J. Bradley, M. Blaze, and M. Hurn Malaria in Britain: 1977-86 Br Med J (Clin Res Ed) 296 6617 1988 245 248
8. D. Christen, R. Steffen, and P. Schlagenhauf Deaths caused by malaria in Switzerland 1988-2002 Am J Trop Med Hyg 75 6 2006 1188 1194
9. T. Jelinek, R. Behrens, Z. Bisoffi, A. Bjorkmann, J. Gascon, and U. Hellgren Recent cases of falciparum malaria imported to Europe from Goa, India, December 2006-January 2007 Eurosurveillance Weekly 12 1 2007 Jan 11 E070111.1
10. A.M. Checkley, A. Smith, V. Smith, M. Blaze, D. Bradley, and P.L. Chiodini Risk factors for mortality from imported falciparum malaria in the United Kingdom over 20 years: an observational study BMJ 344 2012 e2116 10.1136/bmj.e2116
11. S. Mali, S.P. Kachur, and P.M. Arguin Division of parasitic diseases and malaria, Center for Global Health. Centers for Disease Control and Prevention (CDC): malaria surveillance-United States, 2010 MMWR Surveill Summ 61 2012 1 17
12. H.H. Askling, J. Nilsson, A. Tegnell, R. Janzon, and K. Ekdahl Malaria risk in travelers Emerg Infect Dis 11 2005 436 441 10.3201/eid1103.040677
13. E. Seringe, M. Thellier, A. Fontanet, F. Legros, O. Bouchaud, and T. Ancelle French national Reference center for imported malaria study group: severe imported Plasmodium falciparum malaria, France, 1996-2003 Emerg Infect Dis 17 2011 807 813
14. T. Jelinek, C.S. Larsen, H. Siikamäki, B. Myrvang, P. Chiodini, and J. Gascon European cluster of imported falciparum malaria from Gambia Euro Surveill 13 2008 pii:19077
15. M.P. Grobusch, and P.G. Kremsner Uncomplicated malaria Curr Top Microbiol Immunol 295 2005 83 104
16. M. Mascarello, B. Allegranzi, A. Angheben, M. Anselmi, E. Concia, and S. Laganà Imported malaria in adults and children: epidemiological and clinical characteristics of 380 consecutive cases observed in Verona Italy J Travel Med 15 2008 229 236
17. F. Legros, O. Bouchaud, T. Ancelle, A. Arnaud, S. Cojean, and J. Le Bras For the French National Reference Centers for imported and autochthonous malaria epidemiology and chemosensitivity network. Risk factors for imported fatal Plasmodium falciparum malaria, France, 1996-2003 Emerg Infect Dis 13 2007 883 888 10.3201/eid1305.060955
18. P. Muentener, P. Schlagenhauf, and R. Steffen Imported malaria (1985-95): trends and perspectives Bull World Health Organ 77 1999 560 566
19. E. D'Ortenzio, N. Godineau, A. Fontanet, S. Houze, O. Bouchaud, and S. Matheron Prolonged Plasmodium falciparum infection in immigrants, Paris Emerg Infect Dis 14 2008 323 326
20. O. Bouchaud, M. Cot, S. Kony, R. Durand, R. Schiemann, and P. Ralaimazava Do African immigrants living in France have long-term malarial immunity? Am J Trop Med Hyg 72 2005 21 25
21. S. Krajden, D.M. Panisko, B. Tobe, J. Yang, and J.S. Keystone Prolonged infection with Plasmodium falciparum in a semi-immune patient Trans R Soc Trop Med Hyg 85 1991 731 732
22. T. Greenwood, T. Vikerfors, M. Sjoberg, G. Skeppner, and A. Farnert Febrile Plasmodium falciparum malaria 4 years after exposure in a man with sickle cell disease Clin Infect Dis 47 2008 e39 e41
23. P.E. Szmitko, M.L. Kohn, and A.E. Simor Plasmodium falciparum malaria occurring 8 years after leaving an endemic area Diagn Microbiol Infect Dis 63 2009 105 107
24. B. Monge-Maillo, B.C. Jiménez, J.A. Pérez-Molina, F. Norman, M. Navarro, and A. Pérez-Ayala Imported infectious diseases in mobile populations, Spain Emerg Infect Dis 15 2009 1745 1752
25. M. Marangi, R. Di Tullio, P.F. Mens, D. Martinelli, V. Fazio, and G. Angarano Prevalence of Plasmodium spp. in malaria asymptomatic African migrants assessed by nucleic acid sequence based amplification Malar J 8 2009 12
26. K.M. Bowers, D. Bell, P.L. Chiodini, J. Barnwell, S. Incardona, and S. Yen Inter-rater reliability of malaria parasite counts and comparison of methods Malar J 8 2009 267
27. E. Petersen, N.T. Marbiah, L. New, and A. Gottschau Comparison of two methods for enumerating malaria parasites in thick blood films Am J Trop Med Hyg 55 1996 485 489
28. J.A. Flegg, P.J. Guerin, N.J. White, and K. Stepniewska Standardizing the measurement of parasite clearance in falciparum malaria: the parasite clearance estimator Malar J 10 2011 339
29. P.L. Chiodini, K. Bowers, P. Jorgensen, J.W. Barnwell, K.K. Grady, and J. Luchavez The heat stability of Plasmodium lactate dehydrogenase-based and histidine-rich protein 2-based malaria rapid diagnostic tests Trans R Soc Trop Med Hyg 101 2007 331 337
30. J.J. van Hellemond, M. Rutten, R. Koelewijn, A.M. Zeeman, J.J. Verweij, and P.J. Wismans Human Plasmodium knowlesi infection detected by rapid diagnostic tests for malaria Emerg Infect Dis 15 2009 1478 1480
31. World Health Organization Rapid diagnostic tests. Results of round 3 2012 http://www.who.int/tdr/publications/tdr-research-publications/rdt-round3/en/ index.html Geneva 2011. [accessed 13.12.12]
32. J. Luchavez, J. Baker, S. Alcantara, V. Belizario Jr., Q. Cheng, and J.S. McCarthy Laboratory demonstration of a prozone-like effect in HRP2-detecting malaria rapid diagnostic tests: implications for clinical management Malar J 10 2011 286
33. P. Gillet, A. Scheirlinck, J. Stokx, A. De Weggheleire, H.S. Chaúque, and O.D. Canhanga Prozone in malaria rapid diagnostics tests: how many cases are missed? Malar J 10 2011 166
34. O.A. Koita, O.K. Doumbo, A. Ouattara, L.K. Tall, A. Konaré, and M. Diakité False-negative rapid diagnostic tests for malaria and deletion of the histidine-rich repeat region of the hrp2 gene Am J Trop Med Hyg 86 2012 194 198
35. J. Baker, M.L. Gatton, J. Peters, M.F. Ho, J.S. McCarthy, and Q. Cheng Transcription and expression of Plasmodium falciparum histidine-rich proteins in different stages and strains: implications for rapid diagnostic tests PLoS One 6 2011 e22593
36. M.P. Grobusch, U. Alpermann, S. Schwenke, T. Jelinek, and D.C. Warhurst False-positive rapid tests for malaria in patients with rheumatoid factor Lancet 353 1999 297
37. M.P. Grobusch, T. Hanscheid, K. Gobels, H. Slevogt, T. Zoller, and G. Rogler Sensitivity of P. vivax rapid antigen detection tests and possible implications for self-diagnostic use Travel Med Infect Dis 1 2003 119 122
38. T. Jelinek Malaria self-testing by travellers: opportunities and limitations Travel Med Infect Dis 2 2004 143 148
39. C.A. Taylor, D.M. Blau, C.R. Diangelo, W.J. Shieh, S.R. Zaki, and P.M. Arguin Knowledge, attitudes, and practices toward malaria risk and prevention among frequent business travelers of a major oil and gas company J Travel Med 18 2011 395 401
40. World Health Organisation Malaria Chapter 7 2012 In International travel and health. Geneva
41. P.N. Newton, M.D. Green, F.M. Fernández, N.P. Day, and N.J. White Counterfeit anti-infective drugs Lancet Infect Dis 6 2006 602 613
42. H.D. Nothdurft, T. Jelinek, S.M. Pechel, F. Hess, H. Maiwald, and A. Marschang Stand-by treatment of suspected malaria in travellers Trop Med Parasitol 46 1995 161 163
43. P. Schlagenhauf, and E. Petersen Malaria chemoprophylaxis: strategies for risk groups Clin Microbiol Rev 21 2008 466 472
44. L.H. Chen, M.E. Wilson, and P. Schlagenhauf Controversies and misconceptions in malaria chemoprophylaxis for travelers JAMA 297 2007 2251 2263
45. World Health Organization Guidelines for the treatment of malaria 2011 WHO Geneva http://www.who.int/malaria/world-malaria-report-2010/en/index.html
46. R.K. Haynes Artemisinin and derivatives: the future for malaria treatment? Curr Opin Infect Dis 14 2001 719 726
47. C.J. Woodrow, R.K. Haynes, and S. Krishna Artemisinins Postgrad Med J 81 2005 71 78
48. G.M. Keating Dihydroartemisinin/Piperaquine. Review of its use in the treatment of uncomplicated Plasmodium falciparum malaria Drugs 72 2012 937 961
49. P. Teja-Isavadharm, G. Watt, C. Eamsila, K. Jongsakul, Q. Li, and G. Keeratithakul Comparative pharmacokinetics and effect kinetics of orally administered artesunate in healthy volunteers and patients with uncomplicated falciparum malaria Am J Trop Med Hyg 65 2001 717 721
50. A. Benakis, M. Paris, L. Loutan, C.T. Plessas, and S.T. Plessas Pharmacokinetics of artemisinin and artesunate after oral administration in healthy volunteers Am J Trop Med Hyg 56 1997 17 23
51. N.X. Khanh, P.J. de Vries, L.D. Ha, C.J. van Boxtel, R. Koopmans, and P.A. Kager Declining concentrations of dihydroartemisinin in plasma during 5-day oral treatment with artesunate for Falciparum malaria Antimicrob Agents Chemother 43 1999 690 692
52. M. Ashton, D.S. Nguyen, V.H. Nguyen, T. Gordi, N.H. Trinh, and X.H. Dinh Artemisinin kinetics and dynamics during oral and rectal treatment of uncomplicated malaria Clin Pharmacol Ther 63 1998 482 493
53. N.J. White Assessment of the pharmacodynamic properties of antimalarial drugs in vivo Antimicrob Agents Chemother 41 1997 1413 1422
54. B.J. Angus, K. Chotivanich, R. Udomsangpetch, and N.J. White In vivo removal of malaria parasites from red blood cells without their destruction in acute Falciparum malaria Blood 90 1997 2037 2040
55. R. Udomsangpetch, B. Pipitaporn, S. Krishna, B. Angus, S. Pukrittayakamee, and I. Bates Antimalarial drugs reduce cytoadherence and rosetting of Plasmodium falciparum J Infect Dis 173 1996 691 698
56. N. Kumar, and H. Zheng Stage-specific gametocytocidal effect in vitro of the antimalaria drug qinghaosu on Plasmodium falciparum Parasitol Res 76 1990 214 218
57. O. Bouchaud, N. Mühlberger, P. Parola, G. Calleri, A. Matteelli, and G. Peyerl-Hoffmann Therapy of uncomplicated falciparum malaria in Europe: MALTHER-a prospective observational multicentre study Malar J 11 2012 212
58. C. Hatz, J. Soto, H.D. Nothdurft, T. Zoller, T. Weitzel, and L. Loutan Treatment of acute uncomplicated falciparum malaria with artemether-lumefantrine in nonimmune populations: a safety, efficacy, and pharmacokinetic study Am J Trop Med Hyg 78 2008 241 247
59. C. Karema, C.I. Fanello, C. van Overmeir, J.P. van Geertruyden, W. van Doren, and D. Ngamije Safety and efficacy of dihydroartemisinin/piperaquine (Artekin) for the treatment of uncomplicated Plasmodium falciparum malaria in Rwandan children Trans R Soc Trop Med Hyg 100 12 2006 Dec 1105 1111
60. C. Naing, J.W. Mak, K. Aung, and J.Y. Wong Efficacy and safety of dihydroartemisinin-piperaquine for treatment of uncomplicated Plasmodium falciparum malaria in endemic countries: meta-analysis of randomised controlled studies Trans R Soc Trop Med Hyg 2012 Dec 4 [Epub ahead of print]
61. N. Valecha, A.P. Phyo, M. Mayxay, P.N. Newton, S. Krudsood, and S. Keomany An open-label, randomised study of dihydroartemisinin-piperaquine versus artesunate-mefloquine for falciparum malaria in Asia PLoS One 5 2010 e11880
62. Q. Bassat, M. Mulenga, H. Tinto, P. Piola, S. Borrmann, and C. Menéndez Dihydroartemisinin-piperaquine and artemether-lumefantrine for treating uncomplicated malaria in African children: a randomised, non-inferiority trial PLoS One 4 2009 e7871
63. F. Borsini, W. Crumb, S. Pace, D. Ubben, B. Wible, and G.X. Yan In vitro cardiovascular effects of dihydroartemisin-piperaquine combination compared with other antimalarials Antimicrob Agents Chemother 56 2012 3261 3270
64. N.J. White Cardiotoxicity of antimalarial drugs Lancet Infect Dis 7 8 2007 Aug 549 558
65. H.H. Askling, F. Bruneel, G. Burchard, F. Castelli, P.L. Chiodini, and M.P. Grobusch Management of imported malaria in Europe Malar J 11 1 2012 Sep 17 328